SG11201706799YA - Peptides for inhibiting angiogenesis - Google Patents
Peptides for inhibiting angiogenesisInfo
- Publication number
- SG11201706799YA SG11201706799YA SG11201706799YA SG11201706799YA SG11201706799YA SG 11201706799Y A SG11201706799Y A SG 11201706799YA SG 11201706799Y A SG11201706799Y A SG 11201706799YA SG 11201706799Y A SG11201706799Y A SG 11201706799YA SG 11201706799Y A SG11201706799Y A SG 11201706799YA
- Authority
- SG
- Singapore
- Prior art keywords
- peptides
- inhibiting angiogenesis
- angiogenesis
- inhibiting
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/10—Peptides having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B3/00—Apparatus for testing the eyes; Instruments for examining the eyes
- A61B3/10—Objective types, i.e. instruments for examining the eyes independent of the patients' perceptions or reactions
- A61B3/102—Objective types, i.e. instruments for examining the eyes independent of the patients' perceptions or reactions for optical coherence tomography [OCT]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B3/00—Apparatus for testing the eyes; Instruments for examining the eyes
- A61B3/10—Objective types, i.e. instruments for examining the eyes independent of the patients' perceptions or reactions
- A61B3/12—Objective types, i.e. instruments for examining the eyes independent of the patients' perceptions or reactions for looking at the eye fundus, e.g. ophthalmoscopes
- A61B3/1241—Objective types, i.e. instruments for examining the eyes independent of the patients' perceptions or reactions for looking at the eye fundus, e.g. ophthalmoscopes specially adapted for observation of ocular blood flow, e.g. by fluorescein angiography
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
- A61F9/007—Methods or devices for eye surgery
- A61F9/008—Methods or devices for eye surgery using laser
- A61F9/00821—Methods or devices for eye surgery using laser for coagulation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
- A61F9/007—Methods or devices for eye surgery
- A61F9/008—Methods or devices for eye surgery using laser
- A61F2009/00844—Feedback systems
- A61F2009/00851—Optical coherence topography [OCT]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
- A61F9/007—Methods or devices for eye surgery
- A61F9/008—Methods or devices for eye surgery using laser
- A61F2009/00861—Methods or devices for eye surgery using laser adapted for treatment at a particular location
- A61F2009/00863—Retina
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
- A61F9/007—Methods or devices for eye surgery
- A61F9/008—Methods or devices for eye surgery using laser
- A61F2009/00861—Methods or devices for eye surgery using laser adapted for treatment at a particular location
- A61F2009/00865—Sclera
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
- A61F9/007—Methods or devices for eye surgery
- A61F9/008—Methods or devices for eye surgery using laser
- A61F2009/00861—Methods or devices for eye surgery using laser adapted for treatment at a particular location
- A61F2009/00872—Cornea
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Heart & Thoracic Surgery (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Biomedical Technology (AREA)
- Surgery (AREA)
- Radiology & Medical Imaging (AREA)
- Medical Informatics (AREA)
- Vascular Medicine (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Optics & Photonics (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Cardiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201562126968P | 2015-03-02 | 2015-03-02 | |
PCT/US2016/020443 WO2016141053A1 (en) | 2015-03-02 | 2016-03-02 | Peptides for inhibiting angiogenesis |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11201706799YA true SG11201706799YA (en) | 2017-09-28 |
Family
ID=55543089
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201706799YA SG11201706799YA (en) | 2015-03-02 | 2016-03-02 | Peptides for inhibiting angiogenesis |
Country Status (19)
Country | Link |
---|---|
US (2) | US9675660B2 (en) |
EP (1) | EP3265110B1 (en) |
JP (1) | JP6896641B2 (en) |
KR (1) | KR20170122762A (en) |
CN (1) | CN107427549B (en) |
AU (1) | AU2016226264B2 (en) |
BR (1) | BR112017018665A2 (en) |
CA (1) | CA2977389A1 (en) |
DK (1) | DK3265110T3 (en) |
ES (1) | ES2820710T3 (en) |
HK (2) | HK1247573A1 (en) |
IL (1) | IL253966B (en) |
MX (1) | MX2017011170A (en) |
PH (1) | PH12017501549B1 (en) |
PL (1) | PL3265110T3 (en) |
RU (1) | RU2708375C2 (en) |
SG (1) | SG11201706799YA (en) |
WO (1) | WO2016141053A1 (en) |
ZA (1) | ZA201705934B (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2019337806A1 (en) * | 2018-09-11 | 2021-05-13 | Anbition S.R.L. | Peptides and medical uses thereof |
WO2020053773A1 (en) * | 2018-09-11 | 2020-03-19 | Anbition S.R.L. | Peptides and medical uses thereof |
CN113755634A (en) * | 2021-10-12 | 2021-12-07 | 河南省农业科学院烟草研究所 | Specific primer for molecular detection of iris rhizopus and detection method thereof |
CN115737677A (en) * | 2022-07-25 | 2023-03-07 | 天津医科大学总医院 | Application of polypeptide-modified gold nanoparticles in preparation of medicine for inhibiting diabetic retinopathy |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4554101A (en) | 1981-01-09 | 1985-11-19 | New York Blood Center, Inc. | Identification and preparation of epitopes on antigens and allergens on the basis of hydrophilicity |
GB9718609D0 (en) | 1997-09-02 | 1997-11-05 | Imp College Innovations Ltd | Fusion protein |
WO2005041887A2 (en) * | 2003-10-29 | 2005-05-12 | The Johns Hopkins University | Pigment epithelium-derived factor, novel biological activity and methods of use |
WO2005046708A1 (en) | 2003-11-06 | 2005-05-26 | Research Development Foundation | Selective inhibitors of nuclear factor-kb activation and uses thereof |
WO2006015385A2 (en) * | 2004-08-06 | 2006-02-09 | Sopherion Therapeutics, Inc. | Anti-angiogenic peptides and methods of use thereof |
CN102264755A (en) * | 2007-08-08 | 2011-11-30 | 得克萨斯大学体系董事会 | Vegfr-1/nrp-1 targeting peptides |
EP2262524A4 (en) * | 2008-04-16 | 2012-07-11 | Univ Utah Res Found | Compositions and methods for treating pathologic angiogenesis and vascular permeability |
FR2940032B1 (en) | 2008-12-23 | 2013-08-09 | Seb Sa | FOOD COOKING BASKET AND CORRESPONDING COOKING SYSTEM |
US20100190691A1 (en) | 2009-01-27 | 2010-07-29 | Trojan Technologies, Ltd | Delivery of nucleic acids using cell-penetrating peptides |
EP2439514A1 (en) | 2010-10-01 | 2012-04-11 | Aqsens Oy | Method, apparatus, and system for examining optically a sample carried in a plurality of wells |
ES2633343T3 (en) * | 2011-06-13 | 2017-09-20 | The Board Of Trustees Of The University Of Illionis | Peptide compositions and methods for treating lung injury, asthma, anaphylaxis, angioedema, systemic vascular permeability syndromes and nasal congestion |
CN102286101B (en) * | 2011-08-08 | 2013-05-08 | 常州亚当生物技术有限公司 | Fab (fragment of antigen binding) fragment Vasculizumab of anti-VEGF (vascular endothelial growth factor) monoclonal antibody and application thereof |
-
2016
- 2016-03-02 CA CA2977389A patent/CA2977389A1/en active Pending
- 2016-03-02 KR KR1020177024830A patent/KR20170122762A/en not_active Application Discontinuation
- 2016-03-02 MX MX2017011170A patent/MX2017011170A/en unknown
- 2016-03-02 DK DK16710568.3T patent/DK3265110T3/en active
- 2016-03-02 US US15/058,938 patent/US9675660B2/en active Active
- 2016-03-02 WO PCT/US2016/020443 patent/WO2016141053A1/en active Application Filing
- 2016-03-02 AU AU2016226264A patent/AU2016226264B2/en active Active
- 2016-03-02 CN CN201680012874.6A patent/CN107427549B/en not_active Expired - Fee Related
- 2016-03-02 BR BR112017018665-9A patent/BR112017018665A2/en active Search and Examination
- 2016-03-02 SG SG11201706799YA patent/SG11201706799YA/en unknown
- 2016-03-02 ES ES16710568T patent/ES2820710T3/en active Active
- 2016-03-02 PL PL16710568T patent/PL3265110T3/en unknown
- 2016-03-02 JP JP2017546208A patent/JP6896641B2/en active Active
- 2016-03-02 RU RU2017133101A patent/RU2708375C2/en active
- 2016-03-02 EP EP16710568.3A patent/EP3265110B1/en active Active
-
2017
- 2017-05-22 US US15/602,096 patent/US10064911B2/en active Active
- 2017-08-13 IL IL253966A patent/IL253966B/en active IP Right Grant
- 2017-08-29 PH PH12017501549A patent/PH12017501549B1/en unknown
- 2017-08-31 ZA ZA2017/05934A patent/ZA201705934B/en unknown
-
2018
- 2018-05-31 HK HK18107178.9A patent/HK1247573A1/en unknown
- 2018-06-07 HK HK18107464.2A patent/HK1248101A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
CA2977389A1 (en) | 2016-09-09 |
HK1248101A1 (en) | 2018-10-12 |
CN107427549B (en) | 2022-01-11 |
US20160256518A1 (en) | 2016-09-08 |
RU2017133101A (en) | 2019-04-02 |
DK3265110T3 (en) | 2020-10-19 |
HK1247573A1 (en) | 2018-09-28 |
MX2017011170A (en) | 2018-04-24 |
US20170258868A1 (en) | 2017-09-14 |
PH12017501549A1 (en) | 2018-02-05 |
PH12017501549B1 (en) | 2018-02-05 |
BR112017018665A2 (en) | 2018-04-24 |
EP3265110B1 (en) | 2020-07-15 |
US10064911B2 (en) | 2018-09-04 |
ZA201705934B (en) | 2018-12-19 |
ES2820710T3 (en) | 2021-04-22 |
AU2016226264A1 (en) | 2017-08-31 |
KR20170122762A (en) | 2017-11-06 |
JP2018508528A (en) | 2018-03-29 |
AU2016226264B2 (en) | 2021-04-01 |
CN107427549A (en) | 2017-12-01 |
RU2017133101A3 (en) | 2019-07-26 |
EP3265110A1 (en) | 2018-01-10 |
JP6896641B2 (en) | 2021-06-30 |
WO2016141053A1 (en) | 2016-09-09 |
US9675660B2 (en) | 2017-06-13 |
RU2708375C2 (en) | 2019-12-06 |
IL253966A0 (en) | 2017-10-31 |
IL253966B (en) | 2019-12-31 |
PL3265110T3 (en) | 2020-12-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB201520559D0 (en) | Peptides | |
HK1248101A1 (en) | Peptides for inhibiting angiogenesis | |
GB201520536D0 (en) | Peptides | |
FI3380115T3 (en) | Peptides from piwil1 | |
GB201520563D0 (en) | Peptides | |
GB201520545D0 (en) | Peptides | |
GB201520562D0 (en) | Peptides | |
GB201520567D0 (en) | Peptides | |
GB201520550D0 (en) | Peptides | |
GB201520544D0 (en) | Peptides | |
GB201520543D0 (en) | Peptides | |
GB201520541D0 (en) | Peptides | |
GB201520539D0 (en) | Peptides | |
GB201520557D0 (en) | Peptides | |
GB201520564D0 (en) | Peptides | |
GB201520558D0 (en) | Peptides | |
GB201520542D0 (en) | Peptides | |
GB201520548D0 (en) | Peptides | |
GB201520570D0 (en) | Peptides | |
GB201520568D0 (en) | Peptides | |
GB201520566D0 (en) | Peptides | |
GB201520553D0 (en) | Peptides | |
GB201520560D0 (en) | Peptides | |
GB201520561D0 (en) | Peptides | |
GB201520537D0 (en) | Peptides |